Supporting Vasculitis SR vaccine
Caterina Bonetto(Italian Medicines Agency), Jan Bonhoeffer(University Children’s Hospital Basel), Saša Živković(University of Pittsburgh), Barbara Pahud(Children's Mercy Hospital), Novilia Sjafri Bachtiar(PT Bio Farma (Indonesia)), Merita Kucuku(University of Medicine Tirana), Giovanna Zanoni(Azienda Ospedaliera Universitaria Integrata Verona), Carmela Santuccio(Italian Medicines Agency), Robert D. M. Hadden(Erasmus MC), Frederick Varricchio(Rutgers, The State University of New Jersey), Yolanda Brauchli Pernus, Seza Özen(Hacettepe University), Francesco Trotta(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), Rebecca E. Chandler(Uppsala Monitoring Centre), Karina A. Top(Dalhousie University), Robert P. Wise(Center for Biologics Evaluation and Research), Patrizia Felicetti(Italian Medicines Agency), Giampiero Girolomoni(University of Verona)
Unknown
January 1, 2015
Cited by 0
Related Papers
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
|New England Journal of Medicine|2001|3.7k
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|UNC Libraries|2020|1.3k
EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides
|Annals of the Rheumatic Diseases|2005|838
EULAR recommendations for the management of familial Mediterranean fever
|Annals of the Rheumatic Diseases|2016|593
Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions
|The Journal of Immunology|2001|553